The DMT Research of Dr. Rick Strassman
Dimethyltryptamine, or DMT, is a compound that throws people into intense states of consciousness far outside the ordinary. What sets it apart from other psychedelics is where it shows up: not only in various plants and animals but inside the human body itself, in the brain, the lungs, and the blood. That biological presence is part of what pulled Dr. Rick Strassman toward it.
Strassman's curiosity started early. As an undergraduate at Stanford, he set himself an enormous target: a full theory of consciousness. He wanted to braid together three strands that most researchers kept separate. DMT, the traditions of Eastern religion, and psychoanalytic theory and practice. The hope was that connections among them might support his ideas about what consciousness actually is.
One of his first concrete questions was about the pineal gland. Could it be a source of DMT produced naturally inside the body? The pineal is a small structure sitting near the center of the brain, sometimes compared in shape to a tiny seahorse. For a long stretch, science had little to say about what it did.
Strassman suspected the gland had a history that predated modern anatomy. He noticed that a range of old funerary and cultural practices seemed to single it out, or at least to treat the brain with unusual care. Consider Egyptian embalming: organs were removed and preserved while the brain was simply thrown away. Maybe there was a reason worth taking seriously for discarding it. He also pointed to timing. The pineal gland forms in a human fetus roughly forty-nine days after conception, and Tibetan religious thought holds that a soul takes about forty-nine days to enter a new body. Coincidences like these, stacked on top of one another, kept feeding his questions about DMT.
Getting approval to study it took patience. The stigma attached to psychedelics made him sit on his proposal, and permission to run the work finally came roughly twenty years after he first conceived of it. The results eventually filled a book, DMT: The Spirit Molecule, where he laid out what he thought his findings implied. Among those claims: that the brain manufactures and actively looks for a certain level of DMT to keep its normal perception running. Another: that the pineal gland, working with DMT, might be the place where consciousness links up with the physical body.
If that link exists, Strassman read it as a hint that consciousness belongs to something larger, a spiritual order that continues after the body is gone. DMT seemed to reinforce that reading in another way too. The states it produces resemble what people report from deep meditation and from near-death experiences. Strassman wanted to test whether the consciousness revealed under DMT matched the consciousness that mystics have described across every age and culture.
He also thought the compound had real therapeutic promise. In one study, working with a group he called 'spiritually sophisticated' volunteers, DMT appeared to help people work through difficult material, both psychologically and spiritually.
In 1990 he began the research in earnest at the University of New Mexico in Albuquerque, looking at DMT and the pineal gland together. He found that the gland contains everything needed to produce DMT. Beyond its long metaphysical reputation, almost no laboratory work had examined what the pineal gland actually does, so his studies helped pin down a function for it and opened new questions about its place in daily life as well as its possible role as a doorway to whatever comes after death.
A parallel case comes from psilocybin, which has been used in therapy to ease the existential dread of terminally ill patients facing the end. Many of those patients say the experience let them grasp something they took to be true about reality: that death is not a full stop and that life is a passage rather than a destination. DMT seems to offer a comparable glimpse, a sense that the self carries on past the body's failure. For Strassman, the pineal gland and DMT form the biological grounding for mystical states, the kind reached in meditation, in other spiritual disciplines, and, notably, at the edge of death.
Once he had established that the pineal gland can make DMT, a further line of inquiry opened: study the effects of extra, 'abnormal' doses from outside the body to confirm what the body's own supply might be for. His work suggested DMT is actively transported into the brain, pulled in deliberately to keep perception functioning at a baseline level. As he put it, the brain seems hardwired to use DMT and to seek it out so we can move through ordinary reality.
There may be more to that baseline than navigation. Beyond shifting how people view death, DMT might help keep perception vivid, acting as a kind of natural guard against depression. Strassman points out that some antipsychotic medications flatten a person's perception of the world, leaving things dull and lifeless. On his account, DMT holds the perceptual apparatus at the right pitch, keeping the world bright and worth looking at, and perhaps softening the fear of dying in the same way psilocybin does for the terminally ill.
He is careful about how any of this is handled. Echoing other researchers working with psychedelics, Strassman puts heavy weight on set and setting. He does not see any psychedelic as good or bad in itself. Whether someone has an optimal emotional, psychological, and spiritual experience depends on their intentions going in and on having a trained guide and a doctor present to help them make sense of what happens. Psychedelics, he warns, can destabilize as readily as they can ground a person, so administering them without experienced supervision is a mistake.
Another therapeutic angle involves what he calls profound mental experiences. The pineal gland is normally shielded from the ordinary wear of stress, but under severe enough pressure, such as a near-death event, it may release an unusual surge of DMT. That surge triggers altered states much like the ones produced by practices meant to pry consciousness loose from the body. Feeling that separation firsthand can leave people with fresh perspective on what life means, along with a steadying reassurance that consciousness will outlast the body.
Buddhism sat at the center of his early thinking. Strassman was drawn to it partly because of the Abhidharma, the Buddhist system that catalogs states of consciousness in what he considered a fairly objective way. That gave him a framework for rating and measuring the states he expected his volunteers to report. For his own role as physician and coach during the sessions, he credited Zen meditation and the 'active passivity' it cultivates, which helped him guide people through their experiences and the beings they said they met.
Those encounters are among the strangest parts of the record. Many volunteers described meeting highly intelligent entities, which Strassman defines as beings or a shared consciousness that takes no human shape. To study the effects, he gave volunteers small, repeated doses of DMT, working to build up their tolerance to it.